APSR2026-867

 
Late-Breaking
Submitted
Oral Presentation
AO24-004
 
 
https://storage.unitedwebnetwork.com/files/1285/1221304-46903-#APSR2026-867_440701.pptx
Format: PPTX Only
 
Format: PDF Only
16. Interstitial Lung Disease
1

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Haruyuki Ishii * Kyorin University Faculty of Medicine Respiratory Medicine Tokyo Japan
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Haruyuki
Ishii
h141@ks.kyorin-u.ac.jp
+819018444507
51-60
Japan
Original Research
Epidemiological and Genetic Characteristics of Secondary Pulmonary Alveolar Proteinosis in Japan
Maximum 25 words
Abstract Content
Secondary pulmonary alveolar proteinosis (SPAP) is a rare disorder frequently associated with hematologic diseases. However, its epidemiological and genetic features remain unclear in general.
We conducted a nationwide retrospective survey of SPAP cases diagnosed between 1999 and 2018. All cases were confirmed to be negative for anti–GM-CSF autoantibodies. Clinical characteristics, underlying diseases, prognosis, and cytogenetic abnormalities were analyzed.
A total of 90 patients were identified, with an estimated annual incidence of 4–6 cases. Hematologic disorders accounted for 87% of underlying conditions, with myelodysplastic syndrome (MDS) being the most frequent (70%). Other causes included autoimmune diseases (12%) and infections (1%).At diagnosis, dyspnea and cough were observed in 45% of patients, fever in 33%, and 22% were asymptomatic. Impaired diffusing capacity was more prominent than restrictive ventilatory dysfunction.The prognosis was poor, with a median survival of 16 months and 2- and 5-year survival rates of 38% and 28%, respectively. Major causes of death included respiratory failure due to PAP progression and infectious complications.Cytogenetic analysis in MDS-associated SPAP revealed a high frequency of chromosome 8 abnormalities (31%), followed by chromosome 1 (28%). Additionally, mutations in RNA splicing factors, particularly U2AF1, were more frequent than in typical MDS.
SPAP is predominantly associated with MDS and has a poor prognosis. The high prevalence of chromosome 8 abnormalities(especially, trisomy 8) and U2AF1 mutations suggests a potential pathogenetic link between specific hematologic alterations and SPAP development.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
proteinosis, myelodysplastic syndrome, trisomy 8
maximum 3 keywords and no abbreviations, separated by commas
We would like to express our sincere gratitude to the many pulmonologists who contributed to this study.
235